FV
Insider
Forbion Growth Management B.V.
10% ownerForbion Growth Management B.V. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $11.7M of NAMS (462,288 sh across 5 lots, as filed), executed Dec 10 2024. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$11.7M
shares × price, as filed
Last traded
Dec 11 2024
Filed Dec 12 2024
Median ADV $32.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $11.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
NAMSRecent filings
NAMSSALE
NewAmsterdam Pharma Company N.V.
View filing →
$11.7M462,288 sh across 5 lots
Exec Dec 10 2024
Filed Dec 12 2024 · 5:30 PM ET ENGNPURCHASE enGene Holdings Inc. View filing → $5.0M
561,797 sh × $8.90
Exec Oct 30 2024
Filed Nov 1 2024 · 5:30 PM ET